The European Patent Office (EPO) has granted patent EP3211072B1 for a method of producing nerve tissue, with an effective date of March 18, 2026. This patent covers specific production methods and their applications, including those related to A61K 35/12 and A61K 35/30.

This grant signifies the formal recognition of intellectual property rights for this specific biotechnological process. Companies operating in the EU within the pharmaceutical and biotechnology sectors should be aware of this granted patent, as it may impact their research, development, and commercialization activities related to nerve tissue production and regenerative medicine. No immediate compliance actions are required for entities not directly involved in infringing the patent's claims.